Company Filing History:
Years Active: 2014-2016
Title: Hyon El Choy: Innovator in Targeted Medical Solutions
Introduction
Hyon El Choy is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical technology, particularly in the development of innovative solutions for targeted drug delivery and genotoxicity assessment. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
Hyon El Choy's latest patents include groundbreaking inventions that address critical medical challenges. One of his notable patents is for "Selective infarcted-tissue-targeting bacteria and use thereof." This invention relates to bacteria that specifically target infarcted tissue, allowing for selective drug delivery and imaging of affected areas. The bacterium developed in this patent has a high affinity for infarcted myocardium or brain tissue, significantly reducing unwanted effects on other organs. This innovation offers remarkable advantages over traditional gene therapy methods.
Another significant patent is the "Method for determining genotoxicity using non-fluorescent proteins." This method involves transforming fish with a nucleotide sequence encoding a non-fluorescent protein and measuring fluorescence to assess the genotoxicity of test substances. The MutaFish system, which utilizes zebrafish, provides a high-throughput and efficient way to evaluate genotoxicity, surpassing conventional methods like the Ames test.
Career Highlights
Hyon El Choy is affiliated with Chonnam National University, where he continues to engage in research and development. His work is characterized by a commitment to advancing medical science through innovative technologies.
Collaborations
Throughout his career, Hyon has collaborated with notable colleagues, including Jung-Joon Min and Hyung Seok Kim. These partnerships have contributed to the success and impact of his research endeavors.
Conclusion
Hyon El Choy is a distinguished inventor whose work in targeted medical solutions is making a significant impact in the field. His innovative patents demonstrate a commitment to improving healthcare through advanced technologies.